(Total Views: 142)
Posted On: 08/15/2022 9:56:00 AM
Post# of 27267

$GNPX News Article - Genprex Announces Safety Review Committee Approves Dose Escalation in Acclaim-1 Phase 1/2 Trial of REQORSA(TM) in Combination with Tagrisso in Non-Small Cell Lung Cancer https://marketwirenews.com/news-releases/genp...91894.html


My Twitter: WhyteStocks